TIDMSUN
RNS Number : 3419F
Surgical Innovations Group PLC
21 March 2022
Surgical Innovations Group plc
("Surgical Innovations", "SI" or the "Company")
Product launch in partnership with CMR Surgical
Design agreement secured for a new surgical Resposable(TM) Port
Access System
Surgical Innovations Group plc (AIM: SUN), the designer,
manufacturer and distributor of innovative medical technology for
minimally invasive surgery ("MIS"), announces the launch of
YelloPort(TM) Elite 5mm, a new surgical Port Access System,
developed in partnership with CMR Surgical ('CMR'), a global
medical devices company dedicated to transforming surgery with
Versius(R), a next-generation surgical robot. Under the design
agreement Surgical Innovations and CMR have signed, the Company
will supply the Resposable(TM) item for each installed CMR
Surgical's Versius Robotic System (â) .
The new YelloPort Elite(TM) 5mm product was designed
specifically for CMR Surgical's Versius Robotic System (â) , though
it is universal in nature and can be used in combination with a
wider range of laparoscopic instrumentation including other robotic
systems. The device is designed to function effectively with
robotic instrumentation and addresses the continuing need for
high-quality cost-effective solutions within laparoscopy surgery,
utilising the Company's Resposable(TM) technology to meet these
clinical needs. YelloPort Elite(TM) 5mm received its CE mark in
February 2022 and will be available globally from April 2022.
This is the first project that Surgical Innovations and CMR
Surgical, two British-based medical device companies, have
collaborated on. Both target international healthcare markets.
Mark Slack, Chief Medical Officer, CMR Surgical, said: "When we
talk to hospitals and clinical teams, we hear how important it is
for them to reduce the environmental impact of the surgical
products and instruments they use. We want to partner with
hospitals to reduce waste and cost, whilst advancing performance.
Working with Surgical Innovations to develop this new port, for use
with our robotic systems, we've been able to do just that."
David Marsh, Chief Executive Officer of Surgical Innovations,
said: "We're delighted to partner with CMR Surgical, a fellow
British medical device company focused in minimally invasive
surgery , to develop this new surgical Port Access System. Our
Resposable(TM) products provide a high-quality hybrid instrument
concept, with the clinical benefits of a small disposable element,
reducing waste by at least 70% compared to fully disposable
alternatives. The project with CMR also creates opportunity to
develop greater partnerships in robotic surgery and utilises our
existing experience in access devices, instrumentation and flex
technology."
For further information please contact:
Surgical Innovations Group plc www sigroupplc com
David Marsh, CEO Tel: 0113 230 7597
Charmaine Day, CFO
Singer Capital Markets (Nominated Tel: 020 7496 3000
Adviser & Broker)
Aubrey Powell / Rachel Hayes
/ Michael Nothnagel
Walbrook PR (Financial PR & Investor Tel: 020 7933 8780 or si@walbrookpr.com
Relations)
Paul McManus / Lianne Applegarth Mob: 07980 541 893 / 07584 391
303
About Surgical Innovations Group plc
The Group specialises in the design, manufacture, sale and
distribution of innovative, high quality medical products,
primarily for use in minimally invasive surgery. Our product and
business development is guided and supported by a key group of
nationally and internationally renowned surgeons across the
spectrum of minimally invasive surgical activity.
We design and manufacture and source our branded port access
systems, surgical instruments and retraction devices which are sold
directly in the UK home market through our subsidiary, Elemental
Healthcare, and exported widely through a global network of trusted
distribution partners. Many of our products in this field are based
on a "resposable" concept, in which the products are part reusable,
part disposable, offering a high quality and environmentally
responsible solution at a cost that is competitive against fully
disposable alternatives.
Elemental also has exclusive UK distribution for a select group
of specialist products employed in laparoscopy, bariatric and
metabolic surgery, hernia repair and breast reconstruction.
In addition, we design and develop medical devices for carefully
selected OEM partners and have also collaborated with a major UK
industrial partner to provide precision engineering solutions to
complex problems outside the medical arena.
We aim for our brands to be recognised and respected by
healthcare professionals in all major geographical markets in which
we operate and provide by development, partnership or acquisition a
broad portfolio of cost effective, procedure specific surgical
instruments and implantable devices that offer reliable solutions
to genuine clinical needs in the operating theatre environment.
Further information
Further details of the Group's businesses and products are
available on the following websites:
www.sigroupplc.com
www.surginno.com
www.elementalhealthcare.co.uk
To receive regular updates by email, please contact
si@walbrookpr.com
About CMR Surgical Limited | www.cmrsurgical.com
CMR Surgical (CMR) is a global medical devices company dedicated
to transforming surgery with Versius(R) , a next-generation
surgical robot.
Headquartered in Cambridge, United Kingdom, CMR is committed to
working with surgeons, surgical teams and hospital partners, to
provide an optimal tool to make robotic minimal access surgery
universally accessible and affordable. With Versius, we are on a
mission to redefine the surgical robotics market with practical,
innovative technology and data that can improve surgical care.
Founded in 2014, CMR Surgical is private limited company backed
by an international shareholder base.
About the Versius(R) Surgical Robotic System
Versius(R) resets expectations of robotic surgery. Versius fits
into virtually any operating room set-up and integrates seamlessly
into existing workflows, increasing the likelihood of robotic
minimal access surgery (MAS). The small, portable and modular
design of Versius allows the surgeon to only use the number of arms
needed for a given procedure.
Biomimicking the human arm, Versius gives surgeons the choice of
optimised port placement alongside the dexterity and accuracy of
small fully-wristed instruments. With 3D HD vision, easy-to adopt
instrument control and a choice of ergonomic working positions, the
open surgeon console has the potential to reduce stress and fatigue
and allows for clear communication with the surgical team. By
thinking laparoscopically and operating robotically with Versius,
patients, surgeons and healthcare professionals can all benefit
from the value that robotic MAS brings.
Versius also captures meaningful data with its wider digital
ecosystem to support a surgeon's continuous learning. Through the
Versius Connect app, Versius Trainer and CMR clinical registry, the
Versius system unleashes can generate a wealth of insights with the
ultimate goal of supporting improvements in surgical care.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
PRLGZGMFNRNGZZM
(END) Dow Jones Newswires
March 21, 2022 03:00 ET (07:00 GMT)
Surgical Innovations (LSE:SUN)
Historical Stock Chart
From Jan 2025 to Feb 2025
Surgical Innovations (LSE:SUN)
Historical Stock Chart
From Feb 2024 to Feb 2025
